IE
VKTX icon

Israel Englander’s Viking Therapeutics VKTX Stock Holding History

Israel Englander’s Portfolio VKTX Stock Details VKTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$651K Sell
16,700
-59,000
-78% -$1.91M ﹤0.01% 4599
2026
Q1 		$2.46M Sell
75,700
-74,300
-50% -$2.39M ﹤0.01% 3667
2025
Q4 		$5.28M Sell
150,000
-54,600
-27% -$1.93M ﹤0.01% 2947
2025
Q3 		$5.38M Buy
204,600
+56,400
+38% +$1.68M ﹤0.01% 3070
2025
Q2 		$3.93M Sell
148,200
-56,800
-28% -$1.5M ﹤0.01% 3237
2025
Q1 		$4.95M Buy
205,000
+41,600
+25% +$1.31M ﹤0.01% 2878
2024
Q4 		$6.58M Buy
163,400
+153,400
+1,534% +$8.75M ﹤0.01% 2578
2024
Q3 		$633K Sell
10,000
-61,600
-86% -$3.61M ﹤0.01% 4639
2024
Q2 		$3.8M Buy
71,600
+61,400
+602% +$4.02M ﹤0.01% 2978
2024
Q1 		$836K Buy
+10,200
New +$454K ﹤0.01% 4454
2023
Q4 		– Sell
-114,400
Closed -$1.27M – 6586
2023
Q3 		$1.27M Sell
114,400
-8,600
-7% -$123K ﹤0.01% 3993
2023
Q2 		$1.99M Sell
123,000
-212,300
-63% -$4.45M ﹤0.01% 3486
2023
Q1 		$5.58M Sell
335,300
-111,400
-25% -$1.15M ﹤0.01% 2508
2022
Q4 		$4.2M Buy
+446,700
New +$1.99M ﹤0.01% 2962

Other funds holding VKTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Israel Englander's VKTX Position: Q2 2026 in Review

Israel Englander increased its Viking Therapeutics (VKTX) stake by 99% in Q2 2026, buying an estimated $8M and bringing the position to 498,172 shares worth $19.4M. The position accounts for 0.01% of the portfolio, ranked #1657.

Israel Englander first reported a position in VKTX in Q4 2017 and has held it in 30 quarters since. The position peaked at $63.9M in Q1 2023. 432 funds tracked by Wall St. Rank hold VKTX as of Q2 2026.

  • Israel Englander held 498,172 shares of Viking Therapeutics worth $19.4M as of Q2 2026.
  • Israel Englander bought 247,647 Viking Therapeutics shares in Q2 2026, an estimated $8M.
  • Viking Therapeutics made up 0.01% of Israel Englander's portfolio in Q2 2026, its #1657 holding.
  • Israel Englander first reported a position in Viking Therapeutics in Q4 2017 and has held it in 30 quarters since.
  • Israel Englander's Viking Therapeutics position peaked at $63.9M in Q1 2023.
  • 432 funds tracked by Wall St. Rank held Viking Therapeutics as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.